News|Articles|November 14, 2023
Infection Intel: AstraZeneca, DayZero and Oxford Nanopore, and More
Staying Ahead with Company Updates and Product Innovations. This week's news is from AstraZeneca, DayZero and Oxford Nanopore, Ohmnilab, and NIH.
Advertisement
Infection Intel is the column for Infection Control Today® (ICT®) that covers the latest news, including updates on product developments, mergers, and more from companies in the infection control and prevention field.
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Infection Control Today
1
The Missing Link in Hand Hygiene: Why Dose Size Determines Performance
2
Handwashing in Focus: Bradley Survey Highlights Behavior Gaps as World Hand Hygiene Day Marks Global Progress
3
Aging with HIV: What the Next Major Challenge Is for Drug Development
4
Lyme Disease Prevention Breakthrough? TNX-4800 Monoclonal Antibody Shows Rapid Protection in Phase 1 Data at World Vaccine Congress 2026
5